translate
en
arrow_drop_down
translate
en
arrow_drop_down
gl
es
Sign in
Research
PORTAL
Groups
Researchers
Results
Antonio
Antela López
Harvard Medical School
Boston, Estados Unidos
You are in
Collaborations
Harvard Medical School
Publications in collaboration with researchers from Harvard Medical School (1)
2017
Raltegravir 1200 mg once daily versus raltegravir 400 mg twice daily, with tenofovir disoproxil fumarate and emtricitabine, for previously untreated HIV-1 infection: a randomised, double-blind, parallel-group, phase 3, non-inferiority trial
The Lancet HIV, Vol. 4, Núm. 11, pp. e486-e494